Navigation Links
Research to shed new light on how statins benefit heart patients
Date:9/20/2007

A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.

Dr Sarah Calaghan from the Universitys Faculty of Biological Sciences has been awarded 80,000 from Heart Research UK to progress her preliminary evidence that statins are directly affecting the heart muscle cell.

For a long time the cardiovascular benefits of statins were considered to be due to reducing cholesterol in the blood, which prevents the build-up of plaques in arteries - a major cause of heart attacks and strokes. But more recently its becoming clear that this is not the only way statins work, she says.

The widely acclaimed family of drugs are known to have beneficial effects for patients at risk of cardiovascular disease and those with established cardiovascular disease, saving up to 9,000 lives a year(1).

Dr Calaghans research suggests that statins are actually having a direct effect on heart cells, specifically the caveolae - tiny indentations in the cell membrane. Caveolae contain signalling molecules that Dr Calaghan has shown to have an active role in controlling the pumping mechanism of the heart.

Caveolae need cholesterol to exist and our research has shown that if cholesterol is removed from the membrane then the caveolae will collapse. This disrupts the function of caveolae-based signalling molecules and affects the hearts pumping mechanism and its ability to change its force of contraction, she explains.

In a healthy person, the hearts rate and force of contraction is increased by adrenaline during exercise or stress producing what is known as the fight or flight response.

We know that statins are beneficial, says Dr Calaghan. But its really important to know exactly why and how they are affecting the heart cells, since the hearts of patients with cardiac disease respond differently to adrenaline than healthy hearts.

Our new research hopes to determine exactly how statins affect caveolae and what impact this has on the way the heart behaves both at rest and during conditions of stress or exercise.

If we can do this it will help us to understand the disease process better, and this in turn has important implications for the development of new ways to treat heart diseases.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Stem cell research- now Nobel Laureates join the debate
3. Researchers urge caution in using ear tube surgery
4. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
5. Spouses and other partners lower blood pressure says new research
6. Researchers Scale to assess the Severity of Epilepsy in Kids
7. More Research Required For COPD
8. Researchers identify the early makers of Neonatal Sepsis
9. OHSU Researchers Announce New Discovery
10. Skin Cancer Research To Go Global
11. Researchers Identify Gene Connected To Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... ... 17, 2017 , ... Corrective Action & Preventive Action for ... Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd      ... action (PA)? , The methods share techniques and tools but they are different ...
(Date:2/17/2017)... ... 17, 2017 , ... MAP Revenue Cycle Solutions (MAP RCS), ... been promoted to Chief Executive Officer. , The need for maximizing reimbursements ... that demands the transition from pay-for-service to pay-for-performance models. By delivering efficient and ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow ... part by the Hospital Readmission Reduction Program (HRRP), the return of a patient to ... hospitals across the nation. While many providers are struggling to leverage limited resources and ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... , Feb. 19, 2017  nThrive™, an ... cycle portfolio and thought leadership at the 2017 ... a category leader award from KLAS. ... discussion focused on how market trends shape the ... particularly a sophisticated, comprehensive Patient Access solution. The ...
(Date:2/18/2017)... , Feb. 17, 2017  Pharmaceutical companies have long ... products either in development or already on the market.   ... the pharma industry to alter how it manages advisory board ... leader Best Practices, LLC conducted a new study focused on ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance ... Biopharma" or the "Company") today announced the presentation ... potent, and orally administered pan-Janus kinase (JAK) inhibitor ... th Congress of the European Crohn,s and ... Company reported further data from its completed Phase ...
Breaking Medicine Technology: